Author Archives: Antigone Barton

Analysis: Global health research and development spending comes home, in disease solutions and dollars

By on .

With budget proposals titled “America First: A Budget Blueprint to Make America Great Again“ for fiscal year 2018, and “An American Budget” for 2019, the premise of White House budget plans that would slash funding for global health research and development to levels not seen since the start of this century seemed predicated on the […]

Yellow fever vaccine entry requirements leave big gaps

By on .

Fewer than a quarter of airplane passengers traveling to countries where yellow fever is endemic  were required to show proof of vaccination against the disease upon arrival, when they were traveling from countries where the disease is not transmitted locally, according to a report released this week by the World Health Organization. The finding, the […]

New Secretary of State a blank slate on global health

By on .

Global infectious diseases responses not addressed Mike Pompeo’s hearing, testimony for Secretary of State confirmation President Trump applauded the confirmation of Mike Pompeo as the new Secretary of State Thursday, saying “He will always put the interests of America first.” In the view of many, including at least his three most recent predecessors, that would […]

Report shows drop in HIV funding threatens gains in high burden, low income countries

By on .

While steady increases in overall spending to prevent and treat HIV since 2000 have greatly diminished the impacts of the pandemic, high-burden and low income countries continue to rely largely on external funding for care, treatment and prevention programs that will be at risk if donor contributions continue to drop, a recent report from a […]

In taking the One Health approach, is Senegal showing the way?

By on .

The following is a guest post by Scott Moreland, PhD of MEASURE Evaluation Recent experience with the threat of Ebola Virus Disease in West Africa, specifically Guinea, has rung a few bells in neighboring Senegal. Approximately 75 percent of new infectious diseases that threaten people have been shown to be zoonotic—that is, originating from animals […]

What we’re reading: The interwoven lessons of infectious disease and opioid responses

By on .

An Opioid Crisis Foretold – This piece from the editorial board of The New York Times provides a brief history of errors in practice and policy that have led to, and sustained previous epidemics of opioid use. Among the lessons recounted here that should have averted and still could inform responses to the present opioid […]

Modeling tool tells when pairing responses to “big three” and neglected diseases is a win-win

By on .

The idea of pairing responses to diseases found in the global south that are so neglected that they are classified by that word with the better-funded, but still constrained responses to the so-called “Big Three” of HIV, tuberculosis and malaria, was not new. Neither was the hope that those combined efforts could streamline infectious disease control […]

Study: Anxiety, depression can lengthen delay between HIV “test and treat”

By on .

Living with severe depression or an anxiety disorder can have a similar impact on patients’ promptness in seeking care following an HIV diagnosis as living far from a clinic, according to study looking at mental health factors among patients diagnosed more than 90 days before their arrival at a South Africa clinic for further testing […]

We’re reading about maintaining and advancing the gains of biomedical research on the ground

By on .

At the tipping point – A decade and a half of U.S. global leadership against three infectious diseases has turned the trajectories of deadly pandemics and created a road map for ending the worldwide health threats posed by AIDS, tuberculosis and malaria, as well as by outbreaks to come. But the advances led by the […]